Pilot shows cross-Europe drug tracing; Aseptic facility up and running;

> A pharma pilot shows that full traceability systems within an open, cross-border supply chain is feasible across Europe, says the BRIDGE industry group. An overview video is available. Report

> Isogen's new 20,000-square-foot science center, a contract aseptic filling and manufacturing facility in Delaware, has successfully completed its media fills and has begun fulfilling a backlog of customer orders. Announcement

> Contract packager Compass Pharma Services has completed capital improvements upgrading its production capabilities to ISO Class 8, for such potent compounds as enzymes, antibiotics, antifolates, antimetabolites and some hormones. Release

> AAI Pharma's pharmaceutical development division has been acquired by Water Street Healthcare Partners, a private-equity concern that plans to invest $75 million in the contract manufacturer, renamed AAIPharma Services Corp. Article

> An internal report from generics maker Mylan says that the practice of overriding safety and efficacy quality control measures was "pervasive" and had occurred during the three shifts running at the West Virginia facility. Article

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot.